Overview

Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe

Status:
Completed
Trial end date:
2020-08-19
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine if the pre-filled syringe (PFS) supports successful preparation and accurate administration of an aflibercept injection. The secondary objective of the study is to assess ocular safety in the study eye.
Phase:
Phase 4
Details
Lead Sponsor:
Regeneron Pharmaceuticals
Treatments:
Aflibercept